Dr Xuemin Zhu
Xuemin Zhu joined HERC in April 2023 as a researcher. Xuemin’s current work focuses on the health economic analysis of StereoTactic radiotherapy for wet age-related macular degeneration and the psychometric assessment of health outcome measures such as EQ-5D, EQ-5D-Y, EQ-HWB and ASCOT in rare genetic diseases.
Prior to her current position, Xuemin worked as a research assistant at the Vanke School of Public Health, Tsinghua University. During her time there, she used health insurance data to evaluate the impacts of the pandemic and a long-term care insurance pilot on healthcare usage. Xuemin completed her PhD in Health Economics from the University of Aberdeen, with a thesis exploring the role of physicians’ risk attitudes and personality traits on decision-making. She was awarded an MSc in Health Economics from the University of York with a thesis focusing on the role of time preference on time trade-off values. Xuemin obtained her BSc in International Economics and Trade (Medical direction) from the China Pharmaceutical University.
Xuemin’s research interests include economic evaluations and stated preference studies, policy evaluation and non-cognitive skills in decision-making.